8th Annual Cell Culture & Bioprocessing Congress, London | 29 – 30 October 2019

Over 450 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.

Over 40 presentations, case studies and panel discussions focusing on the key issues in cell line optimisation, 3D cell culture, bioprocessing technologies and cell banking.

Featuring the following key themes:

• Cell Line Development & Engineering
• Genomic Approaches to Cell Line Development
• 3D Cell Culture Models & Applications
• Upstream Bioprocessing & Analytics
• Downstream Bioprocessing

Alongside the main programme, new for 2019 the event will include a featured session on Cell Banking on Day 1.

For Orbit Discovery Seunghee Kang, Lydia Aschauer, Sarah Collins and Michelle Adsett will attend this conference.


ELRIG Drug Discovery, Liverpool | 5 – 6 November 2019

Drug Discovery 2019 – Looking Back To The Future

Now in its 13th year, ELRIG’s flagship conference Drug Discovery 2019 will take place at ACC in Liverpool.

This year’s focus, ‘A Look Back to the Future’ is planned to include plenary introductions assessing how we got to where we are now and setting the challenges for discovering the drugs of the future. These will be followed by cutting edge talks and examples of new directions in drug discovery.

Our scientific programme will feature over 40 world-class speakers with 6 main session tracks. In partnership with key academic and charitable groups, we will also run joint disease and biology-oriented tracks focusing on the basic sciences that underpin successful drug discovery.

For Orbit Discovery, Kathleen Humphreys, Christel Compper and Madeleine Smee will attend this conference.


Peptide Therapeutics Symposium, La Jolla | 24 – 25 October 2019

The (SALK) Peptide Therapeutics Symposium was established in 2005 as an annual scientific meeting that brings together world leaders in peptide research from academia and the biopharmaceutical industries.
The meeting’s focus is advances in core technology pertinent to peptide-based drug discovery and therapeutic candidate development. The unique format provides an intense set of lectures through a period of just over twenty-four hours, starting midday Thursday and concluding end of day Friday.

Please join us for the 14th Annual Peptide Therapeutics Symposium taking place October 24th and 25th, 2019 at the Salk Institute for Biological Studies in La Jolla, California. This year’s Symposium continues the tradition of excellence in presenting ‘best of the best’ advances in the field of peptide therapeutics.

For Orbit Discovery Zeke Nims and Alex Batchelor will be attending the symposium.


ELRIG Discovery Technologies, Alderley Park | 26 September 2019

Location: Alderley Park Conference, Macclesfield

Following the success of our inaugral meeting in 2018, ELRIG is pleased to invite you to the 2nd Discovery Technologies meeting to be held at Alderley Park, Macclesfield, UK on September 26th, 2019.

This ELRIG meeting, which will be run in collaboration with Alderley Park, will focus on novel and emerging technologies that are improving the efficiency and success rates in the drug discovery process.

The three main themes of the conference will be the application of imaging techniques in drug discovery and approaches and technologies used to address early safety assessment within the pharmaceutical industry and mechanistic enzymology in drug discovery.

Orbit Discovery will be represented by Emeline Sautron, James Ward, Li Phing Liew and Angela Moncada Pazos.


Boulder Peptide Symposium | 23 – 26 September 2019

The Boulder Peptide Symposium seeks to bring together key decision leaders from both industry and academia to discuss the future of peptide therapeutics. Peptide therapeutics are potent and highly selective yet their development into effective treatments can be challenged by limited delivery routes, product stability, manufacturing challenges and an evolving regulatory landscape. BPS is the key forum where these challenges will be identified, discussed, and one day—addressed.

For Orbit Discovery, Zeke Nims and Xiaoyan Pan will be attending this symposium.


Discovery on Target Boston | 16 – 19 September 2019

Westin Copley Place, Boston, MA – USA

The 17th Annual Discovery on Target (DOT), the industry’s preeminent event on novel drug targets and technologies, will convene over 1,300 drug discovery professionals in Boston, MA, on September 16-19, 2019. This event highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.

Delegates can customize their experience at the event by choosing from 14 conference programs, plus focused training seminars, comprehensive short courses, moderated roundtables and networking functions to meet their own research needs and those of their organizations.

For Orbit Discovery, Zeke Nims (Discovery Leader) will be present. Feel free to have a chat with him.


Basel LIFE | 9 -12 September 2019

Congress Center BASEL – Switzerland

BASEL LIFE is Europe’s leading congress in the Life Sciences, showcasing cutting-edge science and technology.

It brings together preeminent researchers in the field, and offers talented young scientists the possibility to present themselves. Basel is the heart of European’s Life Sciences landscape.

The Innovation Forums investigate how to apply research findings for biotechnology and therapeutic advancement. The 2019 program brings 10 exciting forum programs.

Our Francesca Billwiller, Giulia Poloni and Bethany Marshall will attend the forum on Peptide Therapeutics and present a poster there.

Close Menu